FiveHundredCents
liked and voted
$Tesla (TSLA.US)$ As the world transitions to more sustainable, automated solutions, Tesla isn’t waiting on the sidelines when it comes to automation. At the ‘We, Robot’ event, the company unveiled a series of ambitious new products aimed at making fully autonomous technology mainstream.
• Cybercab: Tesla’s flagship robotaxi aims to disrupt urban mobility. With no steering wheel or pedals, the Cybercab represents a new era of driverless t...
• Cybercab: Tesla’s flagship robotaxi aims to disrupt urban mobility. With no steering wheel or pedals, the Cybercab represents a new era of driverless t...
10
2
FiveHundredCents
liked and voted
$Tesla (TSLA.US)$ July surge fueled by Robo Taxi rumors. That surge was a classic case of "buy the rumor, sell the news," illustrating how markets often price in events before they actually happen. Musk's statement hinting at Cybercab production "before 2027" has raised eyebrows, given his history of missed deadlines. 🤔
Tesla has recently secured approval from local authorities near its Berlin gigafactory to proceed with a three-stage expa...
Tesla has recently secured approval from local authorities near its Berlin gigafactory to proceed with a three-stage expa...
16
4
FiveHundredCents
liked
$Tesla (TSLA.US)$
Leg 1:
Support Established: Leg 1, identified a critical support level at $186.
Leg 2:
Testing and Holding Support: In Leg 2, the market tested the support level established in Leg 1. Importantly, the support at $186 held firm, allowing the trend to continue and form the basis for Leg 3.
Leg 3:
Support Failure: Moving into Leg 3, the trend attempted to establish a new higher support level at $262. However, this support level was not maintai...
Leg 1:
Support Established: Leg 1, identified a critical support level at $186.
Leg 2:
Testing and Holding Support: In Leg 2, the market tested the support level established in Leg 1. Importantly, the support at $186 held firm, allowing the trend to continue and form the basis for Leg 3.
Leg 3:
Support Failure: Moving into Leg 3, the trend attempted to establish a new higher support level at $262. However, this support level was not maintai...
14
2
When discussing Chinese equities, the overall sentiment has shifted dramatically towards optimism. The nation’s recently announced stimulus package has propelled Chinese stocks traded in Hong Kong to their best weekly surge in nearly 13 years, setting them on a path to be among the world’s top performers in 2024. Furthermore, market participants jumping on the rally have driven the cost of volatility hedges for the next month to ...
15
FiveHundredCents
liked
Conventional wisdom favors growth-focused stocks when the Fed shifts to looser monetary policy, and Thursday was no exception, as the S&P’s information technology sector out shadowed its counterparts, gaining 3.1%, outpacing the index’s 1.8% bounce.
$Apple (AAPL.US)$ and $NVIDIA (NVDA.US)$ added the most market value of any public U.S. firms Thursday, as Apple stock’s 3.7% gain tacked on $124 billion to the iPhone maker’s market ...
$Apple (AAPL.US)$ and $NVIDIA (NVDA.US)$ added the most market value of any public U.S. firms Thursday, as Apple stock’s 3.7% gain tacked on $124 billion to the iPhone maker’s market ...
6
FiveHundredCents
liked
$Micron Technology (MU.US)$
👉 Key Highlights:
📍 Ackerman slashes Micron stock price target by $73, bringing it to $67 per share.
📍 Ackerman forecasts Micron will underperform AI peers through 2025 due to an oversupply of high-bandwidth memory.
📍 Raymond James analyst Srini Pajjuri reduces Micron price target from $160 to $125, maintaining an Outperform rating.
📍 Micron's capital expendit...
👉 Key Highlights:
📍 Ackerman slashes Micron stock price target by $73, bringing it to $67 per share.
📍 Ackerman forecasts Micron will underperform AI peers through 2025 due to an oversupply of high-bandwidth memory.
📍 Raymond James analyst Srini Pajjuri reduces Micron price target from $160 to $125, maintaining an Outperform rating.
📍 Micron's capital expendit...
2
2
FiveHundredCents
liked
$NVIDIA (NVDA.US)$
At the Goldman Sachs Communacopia and Technology Conference, Jensen Huang, President and CEO of NVIDIA, shared key insights into NVIDIA's journey, the future of accelerated computing, and the role of artificial intelligence (AI) in transforming industries. Here's a breakdown of the key highlights and expert statements from the discussion:
1. Evolution of NVIDIA: From Gaming to...
At the Goldman Sachs Communacopia and Technology Conference, Jensen Huang, President and CEO of NVIDIA, shared key insights into NVIDIA's journey, the future of accelerated computing, and the role of artificial intelligence (AI) in transforming industries. Here's a breakdown of the key highlights and expert statements from the discussion:
1. Evolution of NVIDIA: From Gaming to...
15
2
FiveHundredCents
liked
🚀 Buckle up for upcoming PDUFAs in September! 👇
$Travere Therapeutic (TVTX.US)$ : FILSPARI (Sparsentan)
$Avadel Pharmaceuticals (AVDL.US)$ : LUMRYZ (FT218)
$Iterum Therapeutics (ITRM.US)$ : Sulopenem - AdCom 🗓️
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Dupixent
$Vanda Pharmaceuticals (VNDA.US)$ : Tradipitant
$Zevra Therapeutics (ZVRA.US)$ : Arimoclomol
$Heron Therapeutics (HRTX.US)$ : ZYNRELEF® Vial Access Needle
$Merck & Co (MRK.US)$ : KEYTRUDA+ chemotherapy
$Bristol-Myers Squibb (BMY.US)$ : KarXT (...
$Travere Therapeutic (TVTX.US)$ : FILSPARI (Sparsentan)
$Avadel Pharmaceuticals (AVDL.US)$ : LUMRYZ (FT218)
$Iterum Therapeutics (ITRM.US)$ : Sulopenem - AdCom 🗓️
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Dupixent
$Vanda Pharmaceuticals (VNDA.US)$ : Tradipitant
$Zevra Therapeutics (ZVRA.US)$ : Arimoclomol
$Heron Therapeutics (HRTX.US)$ : ZYNRELEF® Vial Access Needle
$Merck & Co (MRK.US)$ : KEYTRUDA+ chemotherapy
$Bristol-Myers Squibb (BMY.US)$ : KarXT (...
10
4
Introduction and Overview
Elon Musk and Donald Trump recently sat down for a highly anticipated and widely viewed interview. Despite facing a massive Distributed Denial of Service (DDoS) attack that nearly thwarted the conversation, the interview was successfully conducted. The discussion spanned various topics, from the assassination attempt on Trump to significant political and social issues. Below are the key highligh...
Elon Musk and Donald Trump recently sat down for a highly anticipated and widely viewed interview. Despite facing a massive Distributed Denial of Service (DDoS) attack that nearly thwarted the conversation, the interview was successfully conducted. The discussion spanned various topics, from the assassination attempt on Trump to significant political and social issues. Below are the key highligh...
21
1